Diana Sun

881 total citations
34 papers, 600 citations indexed

About

Diana Sun is a scholar working on Public Health, Environmental and Occupational Health, Surgery and Immunology. According to data from OpenAlex, Diana Sun has authored 34 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 6 papers in Surgery and 6 papers in Immunology. Recurrent topics in Diana Sun's work include Erythropoietin and Anemia Treatment (5 papers), Opioid Use Disorder Treatment (5 papers) and Drug-Induced Adverse Reactions (4 papers). Diana Sun is often cited by papers focused on Erythropoietin and Anemia Treatment (5 papers), Opioid Use Disorder Treatment (5 papers) and Drug-Induced Adverse Reactions (4 papers). Diana Sun collaborates with scholars based in United States, Switzerland and Chile. Diana Sun's co-authors include Ivo Abraham, Ivo Abraham, Matti Aapro, Karen MacDonald, Paul Cornes, Marc E. Grossman, Ahmed E. Altyar, William H. Frishman, Lucy M. Han and Mitchell J. Weiss and has published in prestigious journals such as Blood, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Diana Sun

32 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diana Sun United States 11 161 127 111 85 68 34 600
A. Amin United States 15 112 0.7× 161 1.3× 66 0.6× 195 2.3× 26 0.4× 27 713
Nigel Baker United Kingdom 13 101 0.6× 250 2.0× 66 0.6× 337 4.0× 470 6.9× 24 1.2k
Taha Koray Şahin Türkiye 18 92 0.6× 200 1.6× 155 1.4× 561 6.6× 9 0.1× 83 1.1k
Steven Ades United States 15 44 0.3× 138 1.1× 87 0.8× 187 2.2× 70 1.0× 41 743
Anna Christofides Canada 17 66 0.4× 83 0.7× 51 0.5× 188 2.2× 389 5.7× 41 927
Feng Tao China 17 77 0.5× 397 3.1× 248 2.2× 415 4.9× 36 0.5× 36 1.3k
Bas Zwart Netherlands 12 311 1.9× 180 1.4× 61 0.5× 105 1.2× 75 1.1× 13 734
Herman E. Kattlove United States 12 32 0.2× 103 0.8× 48 0.4× 127 1.5× 209 3.1× 17 695
Joseph T. Santoso United States 18 31 0.2× 92 0.7× 39 0.4× 288 3.4× 23 0.3× 47 920
Colleen Pelser United States 11 72 0.4× 87 0.7× 80 0.7× 337 4.0× 33 0.5× 16 828

Countries citing papers authored by Diana Sun

Since Specialization
Citations

This map shows the geographic impact of Diana Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Sun more than expected).

Fields of papers citing papers by Diana Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Sun. The network helps show where Diana Sun may publish in the future.

Co-authorship network of co-authors of Diana Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Sun. A scholar is included among the top collaborators of Diana Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Sun. Diana Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Diana, et al.. (2024). Forensic evidence in sexual assault laws: a content analysis of state statutes in the United States of America. Journal of Crime and Justice. 48(4). 425–444.
2.
Sun, Diana, et al.. (2023). Staying under the Radar? Immigration Effects on Overdose Deaths and the Impact of Sanctuary Jurisdictions. Societies. 13(6). 135–135. 1 indexed citations
3.
Shannon, Carol, Jong Seok Lee, & Diana Sun. (2023). INDOMETHACIN AS AN ALTERNATIVE TO ASPIRIN IN DETERMINING NSAID HYPERSENSITIVITY REACTION TYPE. Annals of Allergy Asthma & Immunology. 131(5). S114–S115.
4.
Willis, Jeffrey R., Ferhina S. Ali, Amitha Domalpally, et al.. (2021). Feasibility Study of a Multimodal, Cloud-Based, Diabetic Retinal Screening Program in a Workplace Environment. Translational Vision Science & Technology. 10(6). 20–20. 1 indexed citations
5.
Sun, Diana, et al.. (2020). Differences in the Rehabilitation Experience: A Case Study Among Two White-Collar Offenders. 2(1). 1 indexed citations
6.
Namazy, Jennifer A., Lucie Blais, Elizabeth Andrews, et al.. (2019). Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. Journal of Allergy and Clinical Immunology. 145(2). 528–536.e1. 97 indexed citations
7.
Wilke, Thomas, et al.. (2019). Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany. Clinical Therapeutics. 42(1). 130–143.e3. 8 indexed citations
8.
Wilke, Thomas, et al.. (2018). PGI1 - ADVERSE EVENTS ASSOCIATED WITH THE TREATMENT OF INFLAMMATORY BOWEL DISEASE IN GERMANY. Value in Health. 21. S142–S142. 2 indexed citations
9.
Warholak, Terri, Lisa E. Hines, Diana Sun, et al.. (2016). Ability and Use of Comparative Effectiveness Research by P&T Committee Members and Support Staff: A 1-Year Follow-up. Journal of Managed Care & Specialty Pharmacy. 22(6). 618–625. 2 indexed citations
10.
Sun, Diana, Tri Murti Andayani, Ahmed E. Altyar, Karen MacDonald, & Ivo Abraham. (2015). Potential Cost Savings From Chemotherapy-Induced Febrile Neutropenia With Biosimilar Filgrastim and Expanded Access to Targeted Antineoplastic Treatment Across the European Union G5 Countries: A Simulation Study. Clinical Therapeutics. 37(4). 842–857. 42 indexed citations
11.
Paralkar, Vikram R., Tejaswini Mishra, Jing Luan, et al.. (2014). Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development. Blood. 123(12). 1927–1937. 133 indexed citations
12.
Malone, Daniel C., Joshua N. Liberman, & Diana Sun. (2013). Effect of an Educational Outreach Program on Prescribing Potential Drug-Drug Interactions. Journal of Managed Care Pharmacy. 19(7). 549–557. 10 indexed citations
13.
Abraham, Ivo, Diana Sun, Alaa Bagalagel, et al.. (2013). Biosimilars in 3D. Bioengineered. 4(4). 203–206. 13 indexed citations
14.
Abraham, Ivo, Lorenzo Villa Zapata, Kris Denhaerynck, et al.. (2013). Hierarchical Modeling of Patient and Physician Determinants of Blood Pressure Outcomes in Adherent vs Nonadherent Hypertensive Patients: Pooled Analysis of 6 Studies With 14,646 Evaluable Patients. Journal of Clinical Hypertension. 15(9). 663–673. 6 indexed citations
15.
Abraham, Ivo & Diana Sun. (2012). The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion. 52(9). 1983–1988. 70 indexed citations
16.
Frishman, William H., et al.. (2002). Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III. Cardiology in Review. 10(6). 337–348. 10 indexed citations
17.
Frishman, William H., et al.. (2002). Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part II. Cardiology in Review. 10(5). 285–300. 11 indexed citations
18.
Frishman, William H., et al.. (2002). Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part I. Cardiology in Review. 10(4). 230–246. 24 indexed citations
19.
Siegel, Daniel M., et al.. (1996). Surgical pearl: A novel cost-effective approach to wound closure and dressings. Journal of the American Academy of Dermatology. 34(4). 673–675. 6 indexed citations
20.
Sun, Diana, et al.. (1994). Adverse Dermatologic Reactions from Antiarrhythmic Drug Therapy. The Journal of Clinical Pharmacology. 34(10). 953–966. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026